Headache disorders, particularly migraine and autonomic cephalalgias, have long stood at the crossroads of vascular, neural, and immune theories. Since the ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced ...

Vistagen , a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called ...

Discusses FDA Approval of TRYNGOLZA for Severe Hypertriglyceridemia and Acute Pancreatitis Risk Reduction June 24, ...

The Huntington's disease market is projected to experience steady growth, supported by progress in precision medicine, rising investments in research and development, and a deeper understanding ...

Recently published Huntington's Disease Market Insights report includes a comprehensive understanding of current treatment ...

Taking magnesium supplements for migraine can help prevent attacks, research says. Learn about the different types of ...

Sanofi's Wayrilz approved in Japan to treat immune thrombocytopenia Wayrilz is a BTK inhibitor that works through multi-immune modulation to help address the underlying causes of immune thrombocytopen ...

In one of oncology's most anatomically complex regions, the difference between an accurate treatment plan and an imprecise ...

Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia Wayrilz is a BTK inhibitor that works through multi-immune modulation to help ...

Detailed price information for Aligos Therapeutics Inc (ALGS-Q) from The Globe and Mail including charting and trades.

Passengers wave inside a bus after being disembarked from the hantavirus-stricken cruise ship MV Hondius at the port of Granadilla in Tenerife, Canary Islands, Spain, Sunday, May 10, 2026. [AP ...